Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Jayastu Senapati"'
Autor:
Jayastu Senapati, Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan M. Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M. Kantarjian
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/cb51845e37254d6d8ab98fdbb4b106f4
Autor:
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A. Abbas, Sanam Loghavi, Gautam Borthakur, Musa Yilmaz, Ghayas C. Issa, Samuel I. Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J. Jabbour, Steven M. Kornblau, Nicholas J. Short, Naveen Pemmaraju, Guillermo Garcia-Manero, Farhad Ravandi, Joseph Khoury, Naval Daver, Hagop M. Kantarjian, Michael Andreeff, Courtney D. DiNardo
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-6 (2023)
Abstract In TP53 wild-type acute myeloid leukemia (AML), inhibition of MDM2 can enhance p53 protein expression and potentiate leukemic cell apoptosis. MDM2 inhibitor (MDM2i) monotherapy in AML has shown modest responses in clinical trials but combini
Externí odkaz:
https://doaj.org/article/e09e6500217f443ab08d9d78cb583310
Autor:
Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract With the improving knowledge of CML and its management, the goals of therapy need to be revisited to ensure an optimal use of the BCR::ABL1 TKIs in the frontline and later-line therapy of CML. In the frontline therapy of CML in the chronic p
Externí odkaz:
https://doaj.org/article/f3199252ca5c405e9dd66942feadd154
Autor:
Fadi Haddad, Elias Jabbour, Marianne Zoghbi, Nicholas Short, Jayastu Senapati, Walid Macaron, Cedric Nasnas, Lewis Nasr, Naveen Pemmaraju, Nitin Jain, William G. Wierda, Gautam Borthakur, Guillermo Montalban-Bravo, Farhad Ravandi, Guillermo Garcia-Manero, Tapan Kadia, Kelly Chien, Jennifer Thankachan, Rebecca Garris, Hagop Kantarjian
Publikováno v:
HemaSphere, Vol 7, p e9487430 (2023)
Externí odkaz:
https://doaj.org/article/2b0e4d5a85a34a2aa5d33686e7ff1549
Autor:
Jayastu Senapati, Hagop Kantarjian, Alexandre Bazinet, Patrick Reville, Gautam Borthakur, Naval Daver, Courtney Dinardo, Alex Bataller, Elias Jabbour, Nicholas Short, Uday R. Popat, Amin Majid Alousi, Elizabeth J. Shpall, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia
Publikováno v:
HemaSphere, Vol 7, p e2853482 (2023)
Externí odkaz:
https://doaj.org/article/6c3dfbb9bbc948369864f42b94c2f571
Autor:
Jayastu Senapati, Aram Bidikian, Farhad Ravandi, Tapan Kadia, Courtney Dinardo, Guillermo Garcia-Manero, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Mark Brandt, Gautam Borthakur
Publikováno v:
HemaSphere, Vol 7, p e62092d4 (2023)
Externí odkaz:
https://doaj.org/article/7cacf3ed0f974bb987139a5532f6a96b
Autor:
Samuel Urrutia, Ziyi LI, Emmanuel Almanza, Alex Bataller, Rashmi Kanagal-Shamanna, Jayastu Senapati, Koji Sasaki, Kelly Chien, Guillermo Montalban-Bravo, Courtney Dinardo, Gautam Borthakur, Carlos Bueso Ramos, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Publikováno v:
HemaSphere, Vol 7, p e04859d5 (2023)
Externí odkaz:
https://doaj.org/article/0f9915bc1a634b8dbc08262f704f4c4f
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
The last decade has seen steadfast progress in drug development in acute myeloid leukemia (AML) which has moved progressively towards genomic-based therapy. With these advances, outcomes in AML have improved but remains far from satisfactory. One app
Externí odkaz:
https://doaj.org/article/0d1b98e2579745808fac6ffe21cb4f8b
Autor:
Dangudubiyyam Sri Krishna Sahitya, Aditya Jandiyal, Arihant Jain, Jayastu Senapati, Saumya Nanda, Mukul Aggarwal, Pradeep Kumar, Sarita Mohapatra, Pallab Ray, Pankaj Malhotra, Manoranjan Mahapatra, Rishi Dhawan
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high morbidity and mortality rates in haematopoietic cell transplantation (HCT) recipients. Factors like mucositis, neutropenia, prolonged hospital stay, and frequent use of
Externí odkaz:
https://doaj.org/article/a261cbbf94e2440ca823a07eb471f56b
Autor:
Jayastu Senapati, Koji Sasaki
Publikováno v:
Cancers, Vol 14, Iss 10, p 2533 (2022)
The most recent two decades have seen tremendous progress in the understanding and treatment of chronic myeloid leukemia, a disease defined by the characteristic Philadelphia chromosome and the ensuing BCR::ABL fusion protein. However, the biology of
Externí odkaz:
https://doaj.org/article/7321b10b53f040678fc59c8c4ed7ba29